
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8359533
[patent_doc_number] => 20120214679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'METHODS AND SYSTEMS FOR EVALUATING THE SENSITIVITY OR RESISTANCE OF TUMOR SPECIMENS TO CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/304990
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 51025
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304990
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304990 | METHODS AND SYSTEMS FOR EVALUATING THE SENSITIVITY OR RESISTANCE OF TUMOR SPECIMENS TO CHEMOTHERAPEUTIC AGENTS | Nov 27, 2011 | Abandoned |
Array
(
[id] => 8253021
[patent_doc_number] => 20120157334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'MIRNAS AS BIOMARKERS FOR DISTINGUISHING BENIGN FROM MALIGNANT THYROID NEOPLASMS'
[patent_app_type] => utility
[patent_app_number] => 13/299226
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 117603
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157334.pdf
[firstpage_image] =>[orig_patent_app_number] => 13299226
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/299226 | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms | Nov 16, 2011 | Issued |
Array
(
[id] => 7807996
[patent_doc_number] => 20120058950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'DETECTION OF NEUROPEPTIDES ASSOCIATED WITH PELVIC PAIN DISORDERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/295036
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9623
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058950.pdf
[firstpage_image] =>[orig_patent_app_number] => 13295036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295036 | DETECTION OF NEUROPEPTIDES ASSOCIATED WITH PELVIC PAIN DISORDERS AND USES THEREOF | Nov 10, 2011 | Abandoned |
Array
(
[id] => 8042255
[patent_doc_number] => 20120070862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'METHODS FOR PRODUCING UNIQUELY DISTINCT NUCLEIC ACID TAGS'
[patent_app_type] => utility
[patent_app_number] => 13/289702
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27800
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20120070862.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289702 | METHODS FOR PRODUCING UNIQUELY DISTINCT NUCLEIC ACID TAGS | Nov 3, 2011 | Abandoned |
Array
(
[id] => 8140591
[patent_doc_number] => 20120094845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'METHODS AND DEVICES FOR ASSESSING INFERTILITY AND/OR EGG QUALITY'
[patent_app_type] => utility
[patent_app_number] => 13/274032
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13410
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094845.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274032 | METHODS AND DEVICES FOR ASSESSING INFERTILITY AND/OR EGG QUALITY | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8465583
[patent_doc_number] => 20120270752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'ANALYZING THE EXPRESSION OF BIOMARKERS IN CELLS WITH MOMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/252069
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 14562
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252069 | ANALYZING THE EXPRESSION OF BIOMARKERS IN CELLS WITH MOMENTS | Oct 2, 2011 | Abandoned |
Array
(
[id] => 9198719
[patent_doc_number] => 20130338034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METABOLIC DISEASES-RELATED ODORANT RECEPTOR GENES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/992128
[patent_app_country] => US
[patent_app_date] => 2011-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30767
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992128
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992128 | Metabolic diseases-related odorant receptor genes and use thereof | Sep 29, 2011 | Issued |
Array
(
[id] => 8056027
[patent_doc_number] => 20120077695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Mesothelioma Biomarkers and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/246388
[patent_app_country] => US
[patent_app_date] => 2011-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 59388
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077695.pdf
[firstpage_image] =>[orig_patent_app_number] => 13246388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/246388 | Mesothelioma Biomarkers and Uses Thereof | Sep 26, 2011 | Abandoned |
Array
(
[id] => 8211040
[patent_doc_number] => 20120129711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'BIOMARKERS FOR THE PROGNOSIS AND HIGH-GRADE GLIOMA CLINICAL OUTCOME'
[patent_app_type] => utility
[patent_app_number] => 13/237255
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19639
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129711.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237255
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237255 | BIOMARKERS FOR THE PROGNOSIS AND HIGH-GRADE GLIOMA CLINICAL OUTCOME | Sep 19, 2011 | Abandoned |
Array
(
[id] => 7711712
[patent_doc_number] => 20120004121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Diagnostic Assay For Source of Inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/231665
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18705
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13231665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231665 | Diagnostic Assay For Source of Inflammation | Sep 12, 2011 | Abandoned |
Array
(
[id] => 9286014
[patent_doc_number] => 08642342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Methods for regulating neural differentiation'
[patent_app_type] => utility
[patent_app_number] => 13/213848
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7887
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213848
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/213848 | Methods for regulating neural differentiation | Aug 18, 2011 | Issued |
Array
(
[id] => 8964023
[patent_doc_number] => 20130203625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/817812
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 44458
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817812
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817812 | SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSIS | Aug 17, 2011 | Abandoned |
Array
(
[id] => 7784630
[patent_doc_number] => 20120046186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs'
[patent_app_type] => utility
[patent_app_number] => 13/211148
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29833
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046186.pdf
[firstpage_image] =>[orig_patent_app_number] => 13211148
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211148 | Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs | Aug 15, 2011 | Abandoned |
Array
(
[id] => 9004312
[patent_doc_number] => 20130225437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'BIOMARKERS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/817215
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13849
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817215
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817215 | BIOMARKERS OF CANCER | Aug 15, 2011 | Abandoned |
Array
(
[id] => 7778175
[patent_doc_number] => 20120040861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'Pancreatic Cancer Biomarkers and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/208903
[patent_app_country] => US
[patent_app_date] => 2011-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 62060
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040861.pdf
[firstpage_image] =>[orig_patent_app_number] => 13208903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/208903 | Pancreatic Cancer Biomarkers and Uses Thereof | Aug 11, 2011 | Abandoned |
Array
(
[id] => 8347347
[patent_doc_number] => 20120208275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'Methods for co-culturing cord blood cells or cord tissue with menstrual multipotent cells'
[patent_app_type] => utility
[patent_app_number] => 13/209123
[patent_app_country] => US
[patent_app_date] => 2011-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18618
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13209123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/209123 | Methods for co-culturing cord blood cells or cord tissue with menstrual multipotent cells | Aug 11, 2011 | Abandoned |
Array
(
[id] => 7767021
[patent_doc_number] => 20120034642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF REPRODUCING IN VITRO THE METABOLIC IDIOSYNCRASY OF HUMANS'
[patent_app_type] => utility
[patent_app_number] => 13/175138
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11211
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034642.pdf
[firstpage_image] =>[orig_patent_app_number] => 13175138
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/175138 | METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF REPRODUCING IN VITRO THE METABOLIC IDIOSYNCRASY OF HUMANS | Jun 30, 2011 | Abandoned |
Array
(
[id] => 7777432
[patent_doc_number] => 20120040457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'SMALL MOLECULES THAT REPLACE OR AGONIZE P53 FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/168880
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040457.pdf
[firstpage_image] =>[orig_patent_app_number] => 13168880
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168880 | Small molecules that replace or agonize p53 function | Jun 23, 2011 | Issued |
Array
(
[id] => 6064537
[patent_doc_number] => 20110201677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/094900
[patent_app_country] => US
[patent_app_date] => 2011-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 20512
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201677.pdf
[firstpage_image] =>[orig_patent_app_number] => 13094900
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094900 | PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME | Apr 26, 2011 | Abandoned |
Array
(
[id] => 7504206
[patent_doc_number] => 20110265195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'UNIQUE ASSOCIATED KAPOSI\'S SARCOMA VIRUS SEQUENCES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/094522
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 44836
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20110265195.pdf
[firstpage_image] =>[orig_patent_app_number] => 13094522
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094522 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | Apr 25, 2011 | Abandoned |